Mirum Pharmaceuticals Inc (MIRM)
EBITDA Growth
-371.55%
Quarterly · Period ending:
MIRM EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-371.55%period ending
Latest reported-371.55%period ending
MIRM Quarterly EBITDA YoY % (-532.64% → -371.55%)
Year-over-year change
High-resolution chart · PNG
MIRM ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -371.548% | |
| -19,379.75% | |
| 131.9666% | |
| 313.3271% | |
| 128.7106% | |
| 74.0496% | |
| 44.1521% | |
| 75.1681% | |
| 78.7649% | |
| 36.6982% | |
| 13.8091% | |
| 44.1553% | |
| -137.4792% | |
| 24.7946% | |
| -149.5507% | |
| 25.7624% | |
| 25.7372% | |
| 31.0534% | |
| 274.3725% | |
| -93.191% | |
| -68.5295% | |
| -122.0378% | |
| -90.435% | |
| -34.8958% | |
| -65.6461% | |
| -243.5115% | |
| -532.6355% |